Resultados globales: 7 registros encontrados en 0.01 segundos.
Artículos, Encontrados 4 registros
Documentos de investigación, Encontrados 3 registros
Artículos Encontrados 4 registros  
1.
12 p, 571.6 KB Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus / Torres, Armando (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Hernández, Domingo (Hospital Regional Universitario de Málaga, Universidad de Málaga, IBIMA, Málaga, Spain) ; Moreso, Francesc (Universitat Autònoma de Barcelona. Departament de Medicina) ; Serón, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ; Burgos, María Dolores (Hospital Regional Universitario de Málaga, Universidad de Málaga, IBIMA, Málaga, Spain) ; Pallardó, Luis M. (Hospital Universitario Dr Peset, Valencia, Spain) ; Kanter, Julia (Hospital Universitario Dr Peset, Valencia, Spain) ; Díaz Corte, Carmen (Hospital Universitario Central de Asturias, Oviedo, Spain) ; Rodríguez, Minerva (Hospital Universitario Central de Asturias, Oviedo, Spain) ; Diaz, Juan Manuel (Institut d'Investigació Biomèdica Sant Pau) ; Silva, Irene (Institut d'Investigació Biomèdica Sant Pau) ; Valdes, Francisco (Complexo Hospitalario Universitario Juan Canalejo, A Coruña, Spain) ; Fernández-Rivera, Constantino (Complexo Hospitalario Universitario Juan Canalejo, A Coruña, Spain) ; Osuna, Antonio (Hospital Universitario Virgen de las Nieves, Granada, Spain) ; Gracia Guindo, María C. (Hospital Universitario Virgen de las Nieves, Granada, Spain) ; Gómez Alamillo, Carlos (Hospital Universitario Marqués de Valdecilla, Santander, Spain) ; Ruiz, Juan C. (Hospital Universitario Marqués de Valdecilla, Santander, Spain) ; Marrero Miranda, Domingo (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Pérez-Tamajón, Lourdes (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Rodríguez, Aurelio (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; González-Rinne, Ana (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Alvarez, Alejandra (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Perez-Carreño, Estefanía (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; de la Vega Prieto, María José (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Henriquez, Fernando (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Spain) ; Gallego, Roberto (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Spain) ; Salido, Eduardo (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Porrini, Esteban (Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain) ; Universitat Autònoma de Barcelona
Despite the high incidence of posttransplant diabetes mellitus (PTDM) among high-risk recipients, no studies have investigated its prevention by immunosuppression optimization. We conducted an open-label, multicenter, randomized trial testing whether a tacrolimus-based immunosuppression and rapid steroid withdrawal (SW) within 1 week (Tac-SW) or cyclosporine A (CsA) with steroid minimization (SM) (CsA-SM), decreased the incidence of PTDM compared with tacrolimus with SM (Tac-SM). [...]
2018 - 10.1016/j.ekir.2018.07.009
Kidney International Reports, Vol. 3 (july 2018) , p. 1304-1315  
2.
15 p, 1.1 MB The Banff 2017 Kidney Meeting Report : Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials / Haas, M. (Cedars-Sinai Medical Center) ; Loupy, A. (University Paris Descartes. INSERM U970 and Necker Hospital. Paris Translational Research Center for Organ Transplantation) ; Lefaucheur, C. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Roufosse, C. (Imperial College London and North West London Pathology) ; Glotz, D. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Serón Micas, Daniel (Hospital Universitari Vall d'Hebron) ; Nankivell, B. J. (Westmead Hospital) ; Halloran, P. F. (University of Alberta) ; Colvin, R. B. (Harvard Medical School. Massachusetts General Hospital) ; Akalin, Enver (Montefiore Medical Center) ; Alachkar, N. (Johns Hopkins University School of Medicine) ; Bagnasco, S. (Johns Hopkins University School of Medicine) ; Bouatou, Y. (Geneva University Hospitals) ; Becker, J. U. (University Hospital of Cologne) ; Cornell, L. D. (Mayo Clinic) ; van Huyen, J. P. Duong (University Paris Descartes. INSERM U970 and Necker Hospital. Paris Translational Research Center for Organ Transplantation) ; Gibson, I. W. (University of Manitoba) ; Kraus, Edward S. (Johns Hopkins University) ; Mannon, R. B. (University of Alabama School of Medicine) ; Naesens, M. (University Hospitals Leuven. University of Leuven & Department of Nephrology) ; Nickeleit, V. (The University of North Carolina School of Medicine) ; Nickerson, P. (University of Manitoba) ; Segev, D. L. (Johns Hopkins Medical Institutions) ; Singh, H. K. (The University of North Carolina School of Medicine) ; Stegall, M. (Mayo Clinic) ; Randhawa, P. (University of Pittsburgh) ; Racusen, L. (Johns Hopkins University School of Medicine) ; Solez, K. (University of Alberta) ; Mengel, M. (University of Alberta) ; Universitat Autònoma de Barcelona
The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications of inflammation in areas of interstitial fibrosis and tubular atrophy (i‐) and its relationship to T cell-mediated rejection (), and the continued evolution of molecular diagnostics, particularly in the diagnosis of antibody‐mediated rejection (). [...]
2018 - 10.1111/ajt.14625
American Journal of Transplantation, Vol. 18, Issue 2 (February 2018) , p. 293-307  
3.
14 p, 167.5 KB The Banff 2015 Kidney Meeting Report : Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology / Loupy, A. (Paris Translational Research Center for Organ Transplantation INSERM U970 & Necker Hospital University Paris Descartes) ; Haas, M. (Cedars‐Sinai Medical Center) ; Solez, K. (University of Alberta) ; Racusen, L. (Johns Hopkins University School of Medicine) ; Glotz, D. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Serón Micas, Daniel (Hospital Universitari Vall d'Hebron) ; Nankivell, B. J. (Westmead Hospital) ; Colvin, R. B. (Harvard Medical School. Massachusetts General Hospital) ; Afrouzian, M. (University of Texas Medical Branch) ; Akalin, E. (Albert Einstein College of Medicine) ; Alachkar, N. (Johns Hopkins University School of Medicine) ; Bagnasco, S. (Johns Hopkins University School of Medicine) ; Becker, J. U. (University Hospital of Cologne) ; Cornell, L. (Mayo Clinic) ; Drachenberg, C. (University of Maryland School of Medicine) ; Dragun, D. (Charité Universitätsmedizin) ; de Kort, H. (Leiden University Medical Center) ; Gibson, I. W. (University of Manitoba) ; Kraus, E. S. (Johns Hopkins University School of Medicine) ; Lefaucheur, C. (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ; Legendre, C. (Paris Translational Research Center for Organ Transplantation INSERM U970 & Necker Hospital University Paris Descartes) ; Liapis, H. (Washington University) ; Muthukumar, T. (New York Presbyterian Hospital‐Weill Cornell Medicine) ; Nickeleit, V. (University of North Carolina) ; Orandi, B. (Johns Hopkins University School of Medicine) ; Park, W. (Mayo Clinic) ; Rabant, M. (Paris Translational Research Center for Organ Transplantation INSERM U970 & Necker Hospital University Paris Descartes) ; Randhawa, P. (University of Pittsburgh. The Thomas E Starzl Transplantation Institute) ; Reed, E. F. (University of California) ; Roufosse, C. (Hammersmith Hospital) ; Seshan, S. V. (Weill Cornell Medicine) ; Sis, B. (University of Alberta) ; Singh, H. K. (University of North Carolina) ; Schinstock, C. (Mayo Clinic) ; Tambur, A. (Northwestern University. Transplant Immunology Laboratory) ; Zeevi, A. (University of Pittsburgh Medical Center) ; Mengel, M. (University of Alberta) ; Universitat Autònoma de Barcelona
The Banff meeting, held in conjunction the Canadian Society of Transplantation in Vancouver, Canada, reviewed the clinical impact of updates of C4d‐negative antibody‐mediated rejection () from the 2013 meeting, reports from active Banff Working Groups, the relationships of donor‐specific antibody tests (anti‐ and non‐) with transplant histopathology, and questions of molecular transplant diagnostics. [...]
2017 - 10.1111/ajt.14107
American Journal of Transplantation, Vol. 17, Issue 1 (January 2017) , p. 28-41  
4.
9 p, 567.0 KB Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers : a randomized study / Espinel Garuz, Eugenia (Vall d'Hebron Hospitals) ; Joven Maried, Jorge (Universitat Rovira i Virgili) ; Gil, Iván (Vall d'Hebron Hospitals) ; Suñé, Pilar (Vall d'Hebron Hospitals) ; Renedo, Berta (Vall d'Hebron Hospitals) ; Fort Ros, Joan (Vall d'Hebron Hospitals) ; Serón Micas, Daniel (Vall d'Hebron Hospitals)
Background: Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are renoprotective but both may increase serum potassium concentrations in patients with chronic kidney disease (CKD). [...]
2013 - 10.1186/1756-0500-6-306
BMC Public health, Vol. 6, N. 306 (August 2013) , p. 1-9  

Documentos de investigación Encontrados 3 registros  
1.
102 p, 5.7 MB La inflamación subclínica del injerto como modulador de la evolución del trasplante renal: repercusión a nivel inmunológico, histológico y sistémico / García Carro, Clara, autor. ; Serón Micas, Daniel, supervisor acadèmic. ; Moreso Mateos, Francesc, supervisor acadèmic. ; Fonollosa Pla, Vicent, supervisor acadèmic. ; Universitat Autònoma de Barcelona. Departament de Medicina.
El trasplante renal es el tratamiento de elección de la ERC terminal. Enlas últimas décadas, ha mejorado de manera notable la supervivenciadel paciente y del injerto a corto y medio plazo. Sin embargo, a los 10años del trasplante, el 25-35% presenta disfunción del órgano,requiriendo tratamiento dialítico. [...]
Kidney transplantation is the treatment of choice for end-stage CKD. In the last decades, graft and patient survival have dramatically improved. However, at 10 years after transplantation, 25-35% of patients present graft failures and the necessity of renal replacement therapy. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2019.  
2.
285 p, 4.1 MB Estudio exploratorio observacional y prospectivo de la maduración de la fístula arteriovenosa (FAV) nativa : estudio "MAFAVI" / Gil Carballeira, Iván, autor. ; Serón Micas, Daniel, supervisor acadèmic. ; Moreso Mateos, Francesc Josep, supervisor acadèmic. ; Vilardell, Miquel, 1946-, supervisor acadèmic. ; Universitat Autònoma de Barcelona. Departament de Medicina.
[Bellaterra] : Universitat Autònoma de Barcelona, 2017.  
3.
142 p, 1.7 MB Alteraciones de la inmunidad innata, inflamación de bajo grado y progresión de la aterosclerosis subclínica en pacientes con enfermedad renal crónica y en trasplantados renales / Azancot, María A., autor. ; Serón Micas, Daniel, supervisor acadèmic. ; Guardia Massó, Jaume, supervisor acadèmic. ; Universitat Autònoma de Barcelona. Departament de Medicina.
Introducción: La enfermedad cardiovascular se presenta de forma muy precoz en los pacientes con enfermedad renal crónica (ERC) y trasplantados renales, siendo la principal causa de mortalidad en estas poblaciones. [...]
Introduction: Cardiovascular disease is prevalent in patients with chronic kidney disease (CKD) and kidney transplants and constitutes a main cause of death in these patients. The classical cardiovascular risk factors (i. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  

Vea también: autores con nombres similares
1 Serón, D.R.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.